The Journal of Organic Chemistry
Page 8 of 11
1
3
1
Methyl 5-phenyl-4,5-dihydroisoxazole-3-carboxylate (5b).76
Clear oil; 130 mg (69%), R = 0.34 (20% Ethylacetate : n-Hex-
ane); FT-IR (neat): υ =; 1715, 1598 cm ; H NMR (500 MHz,
CDCl ): δ (ppm) 7.39-7.31 (m, 5H), 5.78 (dd, J = 11.5, 9.0 Hz,
1H), 3.89 (s, 3H), 3.64 (dd, J = 18.0, 11.5 Hz, 1H), 3.22 (dd, J
2
H), 6.75 (s, 1H), 5.17 (s, 2H), 3.98 (s, 3H); C{ H} NMR (100
1
2
3
4
5
6
7
8
9
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
6
MHz, CDCl
): δ (ppm) 169.8, 160.1, 158.0 (d, J = 238.8 Hz),
156.3, 153.6 (d, J = 2.2 Hz), 116.2 (d, J = 23.2 Hz), 116.1 (d, J
= 8.1 Hz), 104.0, 61.8, 52.9; HRMS (EI-Quadrupole): m/z =
3
f
-1 1
3
+
2
51.0592, calcd. for C12
H10FNO
4
(M ): 251.0594.
1
3
1
=
3
18.0, 9.0 Hz, 1H); C{ H} NMR (125 MHz, CDCl ): δ (ppm)
Ethyl 5-decylisoxazole-3-carboxylate (3u). Clear oil; 312 mg
92%), R = 0.52 (20% Ethylacetate : n-Hexane); FT-IR (neat):
υ = 1719, 1590 cm ; H NMR (500 MHz, CDCl
160.9, 150.9, 139.4, 128.9, 128.7, 125.8, 85.0, 52.8, 41.3.
(
f
-1
1
3
): δ (ppm) 6.33
s, 1H), 4.37-4.35 (m, 2H), 2.73-2.70 (m, 2H), 1.66-1.61 (m,
3-Ethyl 5-methyl 4,5-dihydroisoxazole-3,5-dicarboxylate
77
(
(5c). Clear oil; 180 mg (77%), R
f
= 0.30 (20% Ethylacetate :
-1
1
3
H), 1.35-1.32 (m, 4H), 1.25-1.18 (m, 12H), 0.82-0.79 (m, 3H);
n-Hexane); FT-IR (neat): υ =1724, 1719, 1591 cm ; H NMR
(500 MHz, CDCl ): δ (ppm) 5.22 (dd, J = 11.0, 8.0 Hz, 1H),
4.36 (q, J = 7.0 Hz, 2H), 3.82 (s, 3H), 3.52-3.49 (m, 2H), 1.38
1
3
1
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
C{ H} NMR (125 MHz, CDCl
): δ (ppm) 175.7, 160.2, 156.3,
3
3
101.4, 61.9, 31.8, 29.5, 29.4, 29.3, 29.1, 28.9, 27.4, 26.7, 22.6,
1
3
1
14.1, 14.0; HRMS (EI-Quadrupole): m/z = 281.1989, calcd. for
3
(t, J = 7.0 Hz, 3H); C{ H} NMR (125 MHz, CDCl ): δ (ppm)
+
C
16
H
27NO
3
(M ): 281.1991.
169.4, 159.8, 151.1, 79.7, 62.4, 53.0, 37.6, 14.1.
7
5
Dimethyl 4,5-dihydroisoxazole-3,5-dicarboxylate (5d).77 Clear
oil; 170 mg (78%), R = 0.34 (20% Ethylacetate : n-Hexane);
FT-IR (neat): υ =1728, 1714, 1597 cm ; H NMR (500 MHz,
CDCl ): δ (ppm) 5.22 (dd, J = 11.5, 8.0 Hz, 1H), 3.90 (s, 3H),
3.82 (s, 3H), 3.53-3.49 (m, 2H); C{ H} NMR (125 MHz,
Phenyl(5-(trimethylsilyl)isoxazol-3-yl)methanone (3v). White
o
o
solid; Mp 33-35 C (lit. 32-34 C); 145mg (71%), R
f
= 0.88
f
-1
1
(
1
20% Ethylacetate : n-Hexane); FT-IR (neat): υ = 3141, 2960,
-1
1
665, 1590 cm ; H NMR (500 MHz, CDCl
3
): δ (ppm) 8.31
3
13
1
(
dd, J = 8.5, 1.5 Hz, 2H), 7.64 (t, J = 7.5 Hz, 1H), 7.52 (t, J =
1
3
1
7
.5 Hz, 2H), 6.97 (s, 1H), 0.41 (s, 9H); C{ H} NMR (125
): δ (ppm) 186.4, 179.4, 160.4, 136.2, 134.0, 130.8,
128.6, 113.6, -1.82.
CDCl
37.6.
3
): δ (ppm) 169.3, 160.2, 150.9, 79.8, 79.8, 53.1, 53.0,
MHz, CDCl
3
Methyl
5-methyl-4,6-dioxo-4,5,6,6a-tetrahydro-3aH-pyr-
7
8
3
-Benzoyl-N-methylisoxazole-5-carboxamide (3w). White
rolo[3,4-d]isoxazole-3-carboxylate (5e). White solid; Mp
207-209 C (lit. 205-208 C); 95 mg (50%), R
o
o
o
solid; Mp 142-144 C; 174 mg (63%), R
f
= 0.43 (50%
f
= 0.30 (50%
-1
-1
Ethylacetate : n-Hexane); FT-IR (neat): υ = 1732, 1625 cm ;
Ethylacetate : n-Hexane); FT-IR (neat): υ = 1726, 1698 cm ;
1
1
H NMR (500 MHz, CDCl
3
): δ (ppm) 8.26 (dd, J = 8.5, 1.0 Hz,
H NMR (500 MHz, DMSO-d
6
): δ (ppm) 5.68 (d, J = 9.5 Hz,
13
1
2
6
H), 7.69-7.65 (m, 1H), 7.53 (t, J = 7.5 Hz, 2H), 7.38 (s, 1H),
1H), 4.80 (d, J = 9.5 Hz, 1H), 3.84 (s, 3H), 2.87 (s, 3H); C{ H}
13
1
.88 (br-s, 1H), 3.06 (d, J = 5.0 Hz, 3H); C{ H} NMR (125
): δ (ppm) 184.7, 164.0, 162.4, 155.9, 135.3, 134.4,
130.6, 128.7, 107.6, 26.4. HRMS (ESI-QTOF): m/z = 231.0757,
NMR (125 MHz, DMSO-d
148.6, 83.5, 54.7, 53.4, 25.6.
6
): δ (ppm) 172.3, 170.7, 159.2,
MHz, CDCl
3
+
Triethyl isoxazole-3,4,5-tricarboxylate (7a).79 Yellow oil; 154
mg (45%), R = 0.42 (20% Ethylacetate : n-Hexane); FT-IR
(neat): υ = 1741, 1735, 1732 cm ; H NMR (500 MHz, CDCl
calcd. for C12
10 2 3
H N O (M+H) : 231.0770.
f
5-(Hydroxymethyl)-isoxazol-3-yl)(phenyl)methanone (3x).75
-1
1
):
δ (ppm) 4.49-4.42 (m, 6H), 1.44-1.38 (m, 9H); C{ H} NMR
(125 MHz, CDCl ): δ (ppm) 159.8, 159.1, 157.9, 155.2, 154.3,
117.9, 63.2, 63.0, 62.8, 13.97, 13.95, 13.93.
(
3
1
3
1
Pale yellow oil; 145mg (68%), R = 0.34 (20% Ethylacetate : n-
Hexane); FT-IR (neat): υ = 3425, 1662, 1593 cm ; H NMR
500 MHz, CDCl ): δ (ppm) 8.27 (dd, J = 8.5, 1.5 Hz, 2H), 7.67-
.63 (m, 1H), 7.52 (t, J = 8.0 Hz, 2H), 6.78 (s, 1H), 4.86 (s, 2H),
f
-1 1
3
(
3
7
2
1
13
1
79
.68 (br-s, 1H); C{ H} NMR (125 MHz, CDCl
3
): δ (ppm)
4,5-Diethyl 3-methyl isoxazole-3,4,5-tricarboxylate (7b). Yel-
low oil; 160 mg (49%), R = 0.41 (20% Ethylacetate : n-Hex-
ane); FT-IR (neat): υ = 1741, 1736, 1731 cm ; H NMR (500
MHz, CDCl ): δ (ppm) 4.49-4.43 (m, 4H), 4.01 (s, 3H), 1.43-
85.8, 172.3, 161.8, 135.6, 134.2, 130.7, 128.6, 102.9, 56.4.
f
-1 1
(5-(1-Hydroxycyclohexyl)isoxazol-3-yl)(phenyl)methanone
3
7
2
13
1
(
3y). Pale yellow oil; 185 mg (84%), R
f
= 0.56 (20%
3
1.38 (m, 6H); C{ H} NMR (125 MHz, CDCl ): δ (ppm) 159.7,
Ethylacetate : n-Hexane); FT-IR (neat): υ = 3517, 2934, 2859,
159.2, 158.4, 155.1, 154.1, 117.9, 63.2, 62.8, 53.5, 13.9.
-
1
1
1
(
2
(
742, 1698 cm ; H NMR (500 MHz, CDCl
dd, J = 8.5, 1.5 Hz, 2H), 7.66-7.63 (m, 1H), 7.52 (t, J = 8.0 Hz,
H), 6.71 (s, 1H), 2.13 (br-s, 1H), 2.03-2.00 (m, 2H), 1.95-1.94
m, 2H), 1.79-1.77 (m, 1H), 1.63-1.59 (m, 2H), 1.41-1.39 (m,
3
): δ (ppm) 8.29
Trimethyl isoxazole-3,4,5-tricarboxylate (7c).79 Yellow solid;
f
170 mg (49%), R = 0.38 (20% Ethylacetate : n-Hexane); Mp
o
-1 1
98-100 C; FT-IR (neat): υ = 1738, 1735, 1731 cm ; H NMR
13
1
13
1
1
H), 1.26-1.25 (m, 1H), 0.99-0.87 (m, 1H); C{ H} NMR (125
): δ (ppm) 185.9, 178.8, 161.7, 135.7, 134.0, 130.7,
28.6, 100.8, 70.4, 36.6, 29.7, 25.1, 21.6, 14.1.
3
(400 MHz, CDCl ): δ (ppm) 4.02 (s, 6H), 3.98 (s, 3H); C{ H}
MHz, CDCl
1
3
NMR (125 MHz, CDCl3): δ (ppm) 160.1, 159.1, 158.4, 155.5,
154.1, 117.8, 53.6, 53.54, 53.52.
Ethyl 5-phenyl-4,5-dihydroisoxazole-3-carboxylate (5a).76
Clear oil; 125 mg (62%), R = 0.31 (20% Ethylacetate : n-Hex-
ane); FT-IR (neat): υ = 1718, 1592 cm ; H NMR (500 MHz,
CDCl ): δ (ppm) 7.39-7.32 (m, 5H), 5.78 (dd, J = 11.5 and 9.0
73
3,4-Bis(ethoxycarbonyl)-1,2,5-oxadiazole 2-oxide (3a′). Yel-
-1 1
low oil; FT-IR (neat): υ = 2987, 1748, 1626 cm ; H NMR (500
MHz, CDCl ): δ (ppm) 4.43 (q, J = 7.0 Hz, 2H), 4.38 (q, J = 7.0
Hz, 2H), 1.36 (t, J = 7.0 Hz, 3H), 1.32 (t, J = 7.0 Hz, 3H);
f
-1 1
3
3
1
3
1
Hz, 1H), 4.36 (q, J = 7.0 Hz, 2H), 3.64 (dd, J = 18.0 and 11.5
Hz, 1H), 3.22 (dd, J = 18.0 and 9.0 Hz, 1H), 1.38 (t, J = 7.0 Hz,
C{ H} NMR (125 MHz, CDCl
3
): δ (ppm) 156.7, 155.1, 148.4,
106.8, 63.7, 13.94, 13.90.
13
1
3
1
H); C{ H} NMR (125 MHz, CDCl
3
): δ (ppm) 160.6, 151.2,
39.5, 128.9, 128.7, 125.9, 84.9, 62.2, 41.5, 14.1.
ASSOCIATED CONTENT
Supporting Information
8
ACS Paragon Plus Environment